Brown-Forman Corporation Class B vs UnitedHealth Group Inc — how do they compare? Brown-Forman Corporation Class B trades at $27.96, while UnitedHealth Group Inc trades at $405.01 (market cap $361.00B). The key difference: UnitedHealth Group Inc pays a 2.31% dividend while Brown-Forman Corporation Class B pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, Brown-Forman Corporation Class B nearer its low. Which is the better fit depends on your goals.
| BF.B | UNH | |
|---|---|---|
Sector | Consumer Staples | Health |
52-Week High | $31.26 | $436.35 |
52-Week Low | $22.80 | $259.02 |
Market Cap | — | $361.00B |
Enterprise Value | — | $402.86B |
Dividend Yield | — | 2.31% |
Signals from Pluang's Aura AI — not financial advice
Brown-Forman Class B (BF.B) trades at $28.03, down 0.57% on the day. The stock shows a bullish technical trend with moving averages supporting upside, while oscillators are neutral. Recent earnings have beaten expectations in three of the last four quarters, with Q2 2024 EPS of $0.48 exceeding the $0.46 estimate. Analyst sentiment is mixed, with a 25% buy rating amid divided coverage.
The outlook is cautiously optimistic given earnings momentum, but risks include competitive pressures and market volatility. Investment appeal hinges on sustained profit growth, though the lack of clear valuation metrics and mixed analyst views suggest a balanced risk-reward profile for investors.
UnitedHealth Group (UNH) trades at $408.74, showing modest daily gains of 0.41% amid a bearish technical signal. The company demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust analyst support (82.7% buy ratings). Recent developments include dividend payments and strategic initiatives to streamline pediatric care authorizations, positioning UNH well in the healthcare sector.
UNH presents a compelling investment case with strong cash flow generation and market leadership, though investors face risks from regulatory scrutiny and margin compression. The stock trades at a discount to analyst consensus target of $476.50, offering potential upside if operational improvements and growth initiatives materialize as projected.
Trailing returns across standard periods
Latest headlines on both assets
Brown-Forman is the largest U.S.-domiciled producer of distilled spirits. The firm reports only a single operating segment, and whiskey represents its primary business driver, generating roughly three-quarters of sales, undergirded by the Jack Daniel's brand as well as bourbons such as Woodford Reserve and Old Forrester. Notable nonwhiskey offerings include tequilas such as el Jimador and Herradura. The firm operates globally, with products sold in more than 170 countries, and adapts its route-to-consumer model depending on regulation as well as the prevailing competitive dynamics in a given market. For example, it sells through distributors in the U.S. but operates its own logistics apparatus in many other countries. The company remains under the control of the Brown family.
Read more on BF.B →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →